Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-28

FDA Approved: NALOXONE HYDROCHLORIDE INJECTION, USP, AUTO-INJECTOR — Original Application (Kaleo, Inc.)

View source ↗

Summary

FDA approved Kaleo’s Naloxone hydrochloride auto-injector for rapid treatment of suspected opioid overdose (NALOXONE HYDROCHLORIDE INJECTION, USP, AUTO-INJECTOR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone hydrochloride auto-injector (Naloxone hydrochloride)

Snippet

ORIG AP for NALOXONE HYDROCHLORIDE INJECTION, USP, AUTO-INJECTOR (NALOXONE HYDROCHLORIDE)